부산대학교 도서관

McDaid, W J; Wilson, L; Adderley, H; Martinez-Lopez, A; Baker, M J; Searle, J; Ginn, L; Budden, T; Aldea, M; Marinello, A; Aredo, J V; Viros, A; Besse, B; Wakelee, H A; Blackhall, F; Castillo-Lluva, S; Lindsay, C R; Malliri, A

Mol Cancer
Molecular Cancer, Vol 23, Iss 1, Pp 1-18 (2024)
McDaid, W J, Wilson, L, Adderley, H, Martinez-Lopez, A, Baker, M J, Searle, J, Ginn, L, Budden, T, Aldea, M, Marinello, A, Aredo, J V, Viros, A, Besse, B, Wakelee, H A, Blackhall, F, Castillo-Lluva, S, Lindsay, C R & Malliri, A 2024, 'The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer', Molecular Cancer, vol. 23, no. 1, pp. 253. https://doi.org/10.1186/s12943-024-02157-x

Giovinazzi, S; Lindsay, C R; Morozov, V M; Escobar-Cabrera, E; Summers, M K; Han, H S; McIntosh, L P; Ishov, A M

Oncogene. 1/5/2012, Vol. 31 Issue 1, p13-26. 14p.

Tay, R Y; Fernández-Gutiérrez, F; Foy, V; Burns, K; Pierce, J; Morris, K; Priest, L; Tugwood, J; Ashcroft, L; Lindsay, C R; Faivre-Finn, C; Dive, C; Blackhall, F

Annals of Oncology. Jul2019, Vol. 30 Issue 7, p1114-1120. 7p. 2 Charts, 1 Graph.

Adderley H; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Blackhall FH; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK.; Lindsay CR; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. colin.lindsay1@nhs.net.; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK. colin.lindsay1@nhs.net.; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK. colin.lindsay1@nhs.net.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Lindsay CR; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. colin.lindsay@gustaveroussy.fr.; Le Moulec S; Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. sylvestre.lemoulec@gmail.com.; Billiot F; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. fanny.billiot@gustaveroussy.fr.; Loriot Y; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Ngo-Camus M; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. maud.ngocamus@gustaveroussy.fr.; Vielh P; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. philippe.vielh@gustaveroussy.fr.; Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. philippe.vielh@gustaveroussy.fr.; Fizazi K; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. karim.fizazi@gustaveroussy.fr.; Massard C; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. christophe.massard@gustaveroussy.fr.; Farace F; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. francoise.farace@gustaveroussy.fr.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Dunnett-Kane V; Manchester University NHS Foundation Trust, Manchester, UK.; Burkitt-Wright E; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.; Blackhall FH; Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, UK; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK.; Malliri A; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Evans DG; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK; Division of Evolution and Genomic Medicine, Faculty of Biology and Health, University of Manchester, Manchester, UK.; Lindsay CR; Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, UK; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: colin.lindsay@manchester.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Lindsay, C R; Blackhall, F H; Carmel, A; Gazzaniga, P; Groen, H J M; Krebs, M G; Muinelo-Romay, L; Pantel, K; Rossi, E; Terstappen, L; Wikman, H; Soria, J-C; Farace, F F; Renehan, A; Dive, C; Besse, B; Michiels, S

Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

Lindsay CR; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Blackhall FH; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Carmel A; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, 114, Rue Edouard Vaillant, Villejuif, 94805, France; INSERM U1018 OncoStat, CESP, Université Paris-Sud, Université Paris-Saclay, France; Ligue Nationale Contre le Cancer Meta-Analysis Platform, Gustave Roussy Cancer Campus, Villejuif, France.; Fernandez-Gutierrez F; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Gazzaniga P; Circulating Tumor Cells Unit, Dept Molecular Medicine, Sapienza, University of Rome, Italy.; Groen HJM; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands.; Hiltermann TJN; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands.; Krebs MG; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Loges S; Department of Tumor Biology, University Medical Center Hamburg - Eppendorf, Hamburg, Germany; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; López-López R; Liquid Biopsy Analysis Unit, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), CIBERONC, Santiago de Compostela, Spain.; Muinelo-Romay L; Liquid Biopsy Analysis Unit, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), CIBERONC, Santiago de Compostela, Spain.; Pantel K; Department of Tumor Biology, University Medical Center Hamburg - Eppendorf, Hamburg, Germany.; Priest L; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; Riethdorf S; Department of Tumor Biology, University Medical Center Hamburg - Eppendorf, Hamburg, Germany.; Rossi E; Department of Surgery, Oncology and Gastroenterology, Oncology Section, University of Padova, Padova, Italy; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Terstappen L; Department of Medical Cell BioPhysics, University of Twente, Enschede, the Netherlands.; Wikman H; Department of Tumor Biology, University Medical Center Hamburg - Eppendorf, Hamburg, Germany.; Soria JC; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U981 'Predictive Biomarkers and New Therapeutics in Oncology', F-94805, Villejuif, France; Paris-Sud University, Orsay, France.; Farace F; INSERM, U981 'Predictive Biomarkers and New Therapeutics in Oncology', F-94805, Villejuif, France; Gustave Roussy, Université Paris-Saclay. 'Rare Circulating Cells' Translational Platform, CNRS UMS3655 - INSERM US23, AMMICA, F-94805, Villejuif, France.; Renehan A; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK.; Dive C; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France; Paris-Sud University, Orsay, France.; Michiels S; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, 114, Rue Edouard Vaillant, Villejuif, 94805, France; INSERM U1018 OncoStat, CESP, Université Paris-Sud, Université Paris-Saclay, France; Ligue Nationale Contre le Cancer Meta-Analysis Platform, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: stefan.michiels@gustaveroussy.fr.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Lindsay CR; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, UK. Electronic address: colin.lindsay@manchester.ac.uk.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, UK; Department of Oncology, University College of London Hospital and UCL Cancer Institute, London, UK.; Forster M; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, UK; Department of Oncology, University College of London Hospital and UCL Cancer Institute, London, UK.; Blackhall F; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, UK.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Lindsay CR; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Faugeroux V; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France.; Pailler E; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Facchinetti F; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Ou D; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Bluthgen MV; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Pannet C; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Ngo-Camus M; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France.; Bescher G; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Caramella C; Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France.; Billiot F; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Remon J; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Planchard D; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Soria JC; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France.; Besse B; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.; Farace F; INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Remon J; Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France.; Abedallaa N; Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France.; Taranchon-Clermont E; Departement d'Anatomie Pathologiques Recherche, Institut Universitaire du Cancer Toulouse - Oncopole, 1 Avenue Irène Joint-Curie, 31509 Toulouse Cedex 9, France. Electronic address: Clermont.Estelle@iuct-oncopole.fr.; Bluthgen V; Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: Maria-Virginia.BLUTHGEN@gustaveroussy.fr.; Lindsay CR; Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: colin.lindsay@gustaveroussy.fr.; Besse B; Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France; University Paris-Sud, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.; Thomas de Montpréville V; Pathology Department, Hôpital Marie Lannelongue, 133, avenue de la Résistance, 92350 Le Plessis-Robinson, France. Electronic address: v.thomasdemontpreville@ccml.fr.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Remon J; Gustave Roussy Cancer Campus, Medical Oncology Department, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: JORDI.REMON-MASIP@gustaveroussy.fr.; Lindsay CR; Gustave Roussy Cancer Campus, Medical Oncology Department, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: colin.lindsay@gustaveroussy.fr.; Bluthgen MV; Gustave Roussy Cancer Campus, Medical Oncology Department, 114 Rue Edouard Vaillant, 94805 Villejuif, France. Electronic address: Maria-Virginia.BLUTHGEN@gustaveroussy.fr.; Besse B; Gustave Roussy Cancer Campus, Medical Oncology Department, 114 Rue Edouard Vaillant, 94805 Villejuif, France; Paris Sud University, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Pailler E; INSERM U981 'Identification of Molecular Predictors and new Targets for Cancer Treatment', University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif.; Auger N; Departments of Biopathology, Gustave Roussy, Villejuif, France.; Lindsay CR; INSERM U981 'Identification of Molecular Predictors and new Targets for Cancer Treatment', University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif.; Vielh P; INSERM U981 'Identification of Molecular Predictors and new Targets for Cancer Treatment', University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif Departments of Biopathology, Gustave Roussy, Villejuif, France.; Islas-Morris-Hernandez A; Translational Research Laboratory, Gustave Roussy, Villejuif.; Borget I; Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France.; Ngo-Camus M; Medicine, Gustave Roussy, Villejuif, France.; Planchard D; Medicine, Gustave Roussy, Villejuif, France.; Soria JC; INSERM U981 'Identification of Molecular Predictors and new Targets for Cancer Treatment', University of Paris-Sud XI, Gustave Roussy, Villejuif Medicine, Gustave Roussy, Villejuif, France.; Besse B; Medicine, Gustave Roussy, Villejuif, France.; Farace F; INSERM U981 'Identification of Molecular Predictors and new Targets for Cancer Treatment', University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif francoise.farace@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Lindsay, C R; Chan, E; Evans, T R; Campbell, S; Bell, P; Stephens, A W; Franke, A; Poondru, S; Rothenberg, M L; Puzanov, I

Journal of Clinical Oncology (J CLIN ONCOL), 5/21/2009 Supplement Part 1 of 2; 27: 2559-2559. (1p)